DMC Biotechnologies wins National Science Foundation grant


In Colorado, DMC Biotechnologies, Inc., a company developing biobased chemicals, has been awarded $500,000 from the National Science Foundation.

The Small Business Innovation Research Phase IIB grant will be used to support commercialization of DMC’s Dynamic Metabolic Control technology. The company’s first product, expected to launch in 2020, will be specialty amino acids for food and feed. DMC’s pipeline also includes biobased chemicals for nutrition, personal care, flavor and fragrance, and fine chemicals.

“We are honored to receive the continued support of the National Science Foundation towards the commercialization of our biobased specialty products,” Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC says in a press release. “The NSF has been a vital partner in DMC’s growth, providing financial support and validation of our technology and business approach.  The strong progress we have made with our projects and partners was instrumental in DMC receiving this supplemental funding from NSF.”